1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Manish Patel: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma Goserelin Acetate, Pembrolizumab - Salivary Gland Carcinoma | Phase 2 | Active not recruiting | Manish Patel | 20 | 2019-05-30 | 2026-07-10 |
Goserelin (1) · pembrolizumab (1)
United States (1)